Researcher profile

Jun-Chau Chien

Jun-Chau Chien contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Dual-aptamer Drift Cancelling Techniques to Improve Long-term Stability of Real-Time Structure-Switching Aptasensors

This paper presents a dual-aptamer scheme to cancel the signal drifts from structure-switching aptamers during long-term monitoring. Electrochemical aptamer-based (E-AB) biosensors recently demonstrated their great potential for in vivo continuous monitoring. Nevertheless, the detection accuracy is often limited by the signaling drifts. Conventionally, these drifts are removed by the kinetic differential measurements (KDM) when coupled with square-wave voltammetry. Yet we discover that KDM does not apply to every aptamer as the responses at different SWV frequencies heavily depend on its structure-switching characteristics and the redox reporters' electron transfer (ET) kinetics. To this end, we present a "dual-aptamer" scheme that uses two aptamers responding differentially to the same molecular target for drift cancellation. We identify these paired aptamers through (1) screening from the existing aptamers pool and (2) engineering the signaling behavior of the redox reporters. We demonstrate their differential signaling to ampicillin and ATP molecules and show that the aptamer pair bears common drifts in undilute goat serum. Through cancellation, sensor drift is reduced by 370-fold. Benefiting from the "differential" signaling, the recording throughput is also doubled using differential readout electronics. The authors believe the proposed technique is beneficial for long-term in vivo monitoring.

preprint2020arXiv

Design and Analysis of a Sample-and-Hold CMOS Electrochemical Sensor for Aptamer-based Therapeutic Drug Monitoring

In this paper, we present the design and the analysis of an electrochemical circuit for measuring the concentrations of therapeutic drugs using structure-switching aptamers. Aptamers are single-stranded nucleic acids, whose sequence is selected to exhibit high affinity and specificity toward a molecular target, and change its conformation upon binding. This property, when coupled with a redox reporter and electrochemical detection, enables reagent-free biosensing with a sub-minute temporal resolution for in vivo therapeutic drug monitoring. Specifically, we design a chronoamperometry-based electrochemical circuit that measures the direct changes in the electron transfer (ET) kinetics of a methylene blue reporter conjugated at the distal-end of the aptamer. To overcome the high-frequency noise amplification issue when interfacing with a large-size (> 0.25 mm2) implantable electrode, we present a sample-and-hold (S/H) circuit technique in which the desired electrode potentials are held onto noiseless capacitors during the recording of the redox currents. This allows disconnecting the feedback amplifiers to avoid its noise injection while reducing the total power consumption. A prototype circuit implemented in 65-nm CMOS demonstrates a cell-capacitance-insensitive input-referred noise (IRN) current of 15.2 pArms at a 2.5-kHz filtering bandwidth. Tested in human whole blood samples, changes in the ET kinetics from the redox-labeled aminoglycoside aptamers at different kanamycin concentrations are measured from the recorded current waveforms. By employing principal component analysis (PCA) to compensate for the sampling errors, a detection limit (SNR = 1) of 3.1 uM under 1-sec acquisition is achieved at 0.22-mW power consumption.